Related references
Note: Only part of the references are listed.New evidence on the management of Lewy body dementia
John-Paul Taylor et al.
LANCET NEUROLOGY (2020)
EEG alpha reactivity and cholinergic system integrity in Lewy body dementia and Alzheimer's disease
Julia Schumacher et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Research criteria for the diagnosis of prodromal dementia with Lewy bodies
Ian G. McKeith et al.
NEUROLOGY (2020)
Diagnostic and prognostic value of EEG in prodromal dementia with Lewy bodies
Jessica Joanne van der Zande et al.
NEUROLOGY (2020)
Quantitative EEG as a biomarker in mild cognitive impairment with Lewy bodies
Julia Schumacher et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
From eyes-closed to eyes-open: Role of cholinergic projections in EC-to-EO alpha reactivity revealed by combining EEG and MRI
Lu Wan et al.
HUMAN BRAIN MAPPING (2019)
Levodopa may affect cortical excitability in Parkinson's disease patients with cognitive deficits as revealed by reduced activity of cortical sources of resting state electroencephalographic rhythms
Claudio Babiloni et al.
NEUROBIOLOGY OF AGING (2019)
Cholinergic muscarinic M1 and M4 receptors as therapeutic targets for cognitive, behavioural, and psychological symptoms in psychiatric and neurological disorders
Daniel Erskine et al.
DRUG DISCOVERY TODAY (2019)
Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease
Jonathan Schulz et al.
BRAIN (2018)
Differences Between Women and Men in Incidence Rates of Dementia and Alzheimer's Disease
Christopher R. Beam et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy bodies
Paul C. Donaghy et al.
PSYCHOLOGICAL MEDICINE (2018)
Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors
Stefan J. Teipel et al.
FRONTIERS IN NEUROLOGY (2018)
In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease
Nicola J. Ray et al.
BRAIN (2018)
Structural grey matter changes in the substantia innominata in Alzheimer's disease and dementia with Lewy bodies: a DARTEL-VBM study
Sean J. Colloby et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2017)
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study
Claudio Babiloni et al.
NEUROBIOLOGY OF AGING (2017)
Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease
Enrica Cavedo et al.
SCIENTIFIC REPORTS (2017)
Differential Atrophy of Hippocampal Subfields: A Comparative Study of Dementia with Lewy Bodies and Alzheimer Disease
Elijah Mak et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2016)
Hippocampal volumes predict risk of dementia with Lewy bodies in mild cognitive impairment
Kejal Kantarci et al.
NEUROLOGY (2016)
Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies
Laura Bonanni et al.
NEUROBIOLOGY OF AGING (2015)
Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer's disease patients
Claudio Babiloni et al.
CLINICAL NEUROPHYSIOLOGY (2013)
Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease
Michel Grothe et al.
NEUROBIOLOGY OF AGING (2013)
Incidence of Dementia With Lewy Bodies and Parkinson Disease Dementia
Rodolfo Savica et al.
JAMA NEUROLOGY (2013)
Atrophy of the Cholinergic Basal Forebrain Over the Adult Age Range and in Early Stages of Alzheimer's Disease
Michel Grothe et al.
BIOLOGICAL PSYCHIATRY (2012)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
The Cholinergic System in Mild Cognitive Impairment and Alzheimer's Disease: An In Vivo MRI and DTI study
Stefan J. Teipel et al.
HUMAN BRAIN MAPPING (2011)
A reproducible evaluation of ANTs similarity metric performance in brain image registration
Brian B. Avants et al.
NEUROIMAGE (2011)
Analysis of the Substantia Innominata Volume in Patients with Parkinson's Disease with Dementia, Dementia with Lewy Bodies, and Alzheimer's Disease
Hee Jin Kim et al.
JOURNAL OF MOVEMENT DISORDERS (2011)
Reactivity of Cortical Alpha Rhythms to Eye Opening in Mild Cognitive Impairment and Alzheimer's Disease: an EEG Study
Claudio Babiloni et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration
Arno Klein et al.
NEUROIMAGE (2009)
EEG comparisons in early Alzheimers disease, dementia with Lewy bodies and Parkinsons disease with dementia patients with a 2-year follow-up
Laura Bonanni et al.
BRAIN (2008)
Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain
Laszlo Zaborszky et al.
NEUROIMAGE (2008)
Rivastigmine effects on EEG spectra and three-dimensional LORETA functional imaging in Alzheimer's disease
Lorena R. R. Gianotti et al.
PSYCHOPHARMACOLOGY (2008)
A fast diffeomorphic image registration algorithm
John Ashburner
NEUROIMAGE (2007)
MR features of the substantia innominata and therapeutic implications in dementias
Haruo Hanyu et al.
NEUROBIOLOGY OF AGING (2007)
Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease
Jennifer L. Whitwell et al.
BRAIN (2007)
A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data
SB Eickhoff et al.
NEUROIMAGE (2005)
Differences in MR features of the substantia innominata between dementia with Lewy bodies and Alzheimer's disease
H Hanyu et al.
JOURNAL OF NEUROLOGY (2005)
Effects of scopolamine on MEG spectral power and coherence in elderly subjects
D Osipova et al.
CLINICAL NEUROPHYSIOLOGY (2003)
Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease
P Tiraboschi et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Share Paper
